Director of Sichuan International Medical Promotion Association
Director of China Medical Biotechnology Association
Overall responsible for the company's strategic management, organization and coordination

Master of Management Engineering from Zhejiang University;
PhD candidate in Global Finance, PBC School of Finance, Tsinghua University;
EMBA, School of Economics and Management, Tsinghua University;
Chengdu JinRui Jiye Biotechnology Co., Ltd. was established in 2009. Over the past 10 years, it continuously cultivate and introduce R&D talents to establish self-dependent R&D team. At the same time, it cooperates with external well-known R&D institutions to focus on the field of innovative drug R&D.

Director,National distinguished expert
Vice president of Zhejiang Overseas High-level talent association, president of biomedical branch
National "Thirteenth Five-Year" major project evaluation expert
Fully responsible for the company's strategic operations, project research and development, etc.

Ph.D. in Analytical Chemistry, Department of Chemistry, Rutgers University, New Jersey, USA;
Dr. TianMin Zhu has served as senior director of drug R&D department of Wyeth and Pfizer, vice president of R&D of Hisun Pharmaceutical Company, and chief scientist of the company.Senior Technology Fellow（Dr. TianMin Zhu is the only scientist in Wyeth history who has won the highest R&D award for two consecutive years. He is also the winner of the 2005 Emerald Award by the American "Science Spectrum" and was awarded the Senior Technology Fellow.Own more than 20 PCT patents and published more than 20 academic papers.

Chairman of the Scientific Advisory Board
JRF101 main patent inventor
Chairman of Sichuan International Medical Promotion Association
Chairman of China Medical Biotechnology Association

Director of State Key Laboratory of Biotherapy, Sichuan University/Director of Clinical Oncology Center of West China Hospital;
Director of national comprehensive New drug research and development technology platform, chief scientist of "973" project of Ministry of Science and Technology;
The second batch of distinguished Professors/recipients of national Outstanding Fund of "Major Talents Program" of the Ministry of Education;
Leader of the comprehensive platform of national Major New Drug Projects of Changjiang Scholars;
Signal Transduction and Targeted Therapy（IF 13.493）Human Gene Therapy Co-editor of Signal Transduction and Targeted Therapy (IF 13.493),editorial board of many international journals such as Human Gene Therapy.